+

WO2007033959A3 - Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas - Google Patents

Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas Download PDF

Info

Publication number
WO2007033959A3
WO2007033959A3 PCT/EP2006/066490 EP2006066490W WO2007033959A3 WO 2007033959 A3 WO2007033959 A3 WO 2007033959A3 EP 2006066490 W EP2006066490 W EP 2006066490W WO 2007033959 A3 WO2007033959 A3 WO 2007033959A3
Authority
WO
WIPO (PCT)
Prior art keywords
lymphomas
modulation
selectin glycoprotein
glycoprotein ligand
metastasis
Prior art date
Application number
PCT/EP2006/066490
Other languages
French (fr)
Other versions
WO2007033959A2 (en
Inventor
Baetselier Patrick De
Geert Raes
Ghassabeh Gholamre Hassanzadeh
Original Assignee
Vib Vzw
Univ Bruxelles
Baetselier Patrick De
Geert Raes
Ghassabeh Gholamre Hassanzadeh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vib Vzw, Univ Bruxelles, Baetselier Patrick De, Geert Raes, Ghassabeh Gholamre Hassanzadeh filed Critical Vib Vzw
Publication of WO2007033959A2 publication Critical patent/WO2007033959A2/en
Publication of WO2007033959A3 publication Critical patent/WO2007033959A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/178—Lectin superfamily, e.g. selectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to the use of P-selectin ligand 1 for the modulation of hematogenous metastasis of lymphomas. More specifically, it relates to the use of P-selectin glycoprotein ligan-1 and of molecules that impair the binding of P-selectin ligand in preventing metastasis, preferably metastasis in liver and spleen.
PCT/EP2006/066490 2005-09-19 2006-09-19 Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas WO2007033959A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05108577.7 2005-09-19
EP05108577 2005-09-19

Publications (2)

Publication Number Publication Date
WO2007033959A2 WO2007033959A2 (en) 2007-03-29
WO2007033959A3 true WO2007033959A3 (en) 2007-11-22

Family

ID=36499205

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/066490 WO2007033959A2 (en) 2005-09-19 2006-09-19 Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas

Country Status (1)

Country Link
WO (1) WO2007033959A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7244422B2 (en) 2017-01-11 2023-03-22 ブリストル－マイヤーズ スクイブ カンパニー PSGL-1 antagonists and uses thereof
CN110740749B (en) 2017-03-14 2024-12-10 戊瑞治疗有限公司 Antibodies that bind to VISTA at acidic pH
JP7510879B2 (en) 2018-03-21 2024-07-04 ファイヴ プライム セラピューティクス インク Antibodies that bind to VISTA at acidic pH
EP3820902A2 (en) 2018-07-11 2021-05-19 Five Prime Therapeutics, Inc. Antibodies binding to vista at acidic ph

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013603A1 (en) * 2001-08-03 2003-02-20 Abgenomics Co. Modulators of p-selectin glycoprotein ligand 1
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001822A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001822A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
WO2003013603A1 (en) * 2001-08-03 2003-02-20 Abgenomics Co. Modulators of p-selectin glycoprotein ligand 1

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BLOOD. 15 JUN 2005, vol. 105, no. 12, 15 June 2005 (2005-06-15), pages 4800 - 4806, ISSN: 0006-4971 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 15 June 2005 (2005-06-15), BÉLANGER SIMON D ET AL: "Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lymphoma.", XP002385398, Database accession no. NLM15705798 *
DE LUCA M ET AL: "A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding", JOURNAL OF BIOLOGICAL CHEMISTRY. (MICROFILMS), AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, 10 November 1995 (1995-11-10), XP002076917 *
FUKUDA M ET AL: "Mucin-type O-glycans and leukosialin", BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE, AMSTERDAM, NL, vol. 1455, no. 2-3, 8 October 1999 (1999-10-08), pages 205 - 217, XP004276907, ISSN: 0925-4439 *
LIM ET AL: "The role of CD24 in various human epithelial neoplasias", PATHOLOGY RESEARCH AND PRACTICE, GUSTAV FISCHER, STUTTGART, DE, vol. 201, no. 7, 31 August 2005 (2005-08-31), pages 479 - 486, XP005020430, ISSN: 0344-0338 *

Also Published As

Publication number Publication date
WO2007033959A2 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
WO2008125623A3 (en) Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9)
WO2009009116A3 (en) Combination therapies employing gitr binding molecules
MX2008011874A (en) Stabilized polypeptide compositions.
WO2008014008A3 (en) Compositions and methods for modulating angiogenesis
WO2009056631A3 (en) Molecules and methods for modulating complement component
WO2007146491A3 (en) Flowable particulates
TW200706644A (en) Pyran-dioxane derivatives, and the use thereof in liquid-crystalline media
WO2006104911A3 (en) Methods and compositions for modulating hyperstabilized c-met
WO2006110651A3 (en) Reflective displays and processes for their manufacture
WO2006085938A3 (en) Il-13 binding agents
EP1718319A4 (en) Compositions enriched in phenolic compounds and methods for producing the same
WO2006122156A3 (en) Compounds for modulating trpv3 function
WO2007056124A3 (en) Compounds for modulating trpv3 function
HK1112005A1 (en) Gitr binding molecules and uses therefor
WO2006130374A3 (en) Tweak binding antibodies
WO2006093524A3 (en) Antigen-carbohydrate conjugates
IL220412A (en) Antibodies which bind to gm-csf, polynucleotides encoding the same, pharmaceutical compositions containing the same and uses thereof
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
IL184111A0 (en) Prostaglandin-containing compositions and methods for enhancing the stability thereof
WO2005086775A3 (en) Lumen-exposed molecules and methods for targeted delivery
AP2006003772A0 (en) 3-OR 4-Monosubstituted phenol and thiophenolderivatives useful as H3 ligands
HK1165444A1 (en) Compositions and methods for modulating hemostasis
TW200643153A (en) Liquid-crystalline medium
WO2007003264A3 (en) Polyaspartic acid derivatives in covering agents containing polysiloxane
TW200719881A (en) Sedative effect-enabling agent and sedative aroma composition comprising the same

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06793627

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06793627

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载